摘要
2011年5月4日,新修订的《药品不良反应报告和监测管理办法》正式颁布。新《办法》对药品不良反应的报告主体之一的医疗机构的职责进行了明确规定。本文旨在结合新《办法》,探讨医疗机构在现今新的药品不良反应监测形式下如何做好监测工作。
The new revision of Provisions for Adverse Drug Reaciton Reporting and Monitoring was promulgated on May 4 2011. The provisions clearled definy the responsibilities of the medical institutions who are one of the main body of adverse drug reaction reporting.Combined with the provisions, this article aims to introduce how the medical institutions to do adverse drug reaction monitoring well during the new period of monitoring.
出处
《中国药物警戒》
2012年第4期224-226,共3页
Chinese Journal of Pharmacovigilance
关键词
医疗机构
药品不良反应监测报告和监测管理办法
药品不良反应监测
Medical institutions
Provisions for Adverse Drug Reaciton Reporting and Monitoring
adverse drug reaction monitoring
